Biomarker Studies Demonstrate On-Target Effects of Tarextumab Against Notch Pathway and Cancer Stem Cells in Patients With Pancreatic Cancer Patient-Derived Preclinical and Clinical Data Support the Phase 2 Development of Demcizumab With Abraxane and Gemcitabine in Pancreatic Cancer
BARCELONA, Spain and REDWOOD CITY, Calif., Nov.
a Sanofi company, announced today that the Committee for Medicinal
Products for Human Use (CHMP) of the European Medicines Agency (EMA) has
adopted a positive opinion recommending approval of Cerdelga ®
(eliglustat) capsules, an oral treatment for certain adults living with
Gaucher disease type 1.
Sign-up for Catalyst Pharmaceuticals Announces Notice of Allowance of U.S. Patent Application for the Reduction or Elimination of Visual Field Defects by Treating Patients With CPP-115 investment picks
International Flavors & Fragrances Inc. (NYSE:IFF), a leading global
creator of flavors and fragrances for consumer products, today announced
the opening of a creative facility in Jakarta, Indonesia, and a sales
office and applications laboratories in Santiago, Chile.
Tenneco Inc. (NYSE: TEN) announced today that it has commenced a cash
tender offer for any and all of its outstanding $225 million 7 3/4%
Senior Notes due 2018 and a solicitation of consents to certain proposed
amendments to the indenture governing the notes.
Celgene International Sàrl (NASDAQ: CELG), a wholly-owned subsidiary of
Celgene Corporation, today announced that the European Medicines
Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has
adopted a positive opinion for OTEZLA® (apremilast), the Company’s oral
selective inhibitor of phosphodiesterase 4 (PDE4), in two therapeutic
Psoriasis is an immune mediated skin condition characterised by raised
scaly lesions on the skin.
Acceleration in migration of approximately 1,900 Co-op Food ATMs to Cardtronics
Exclusive ATM provider to Co-operative Food through 2022
Migration to commence late 2014 and complete over the course of 2015
Sign-up for PTP INVESTOR ALERT: Levi & Korsinsky, LLP Announces Investigation of the Board of Directors of Platinum Underwriters Holdings Ltd. in Connection With the Fairness of the Sale of the Company to RenaissanceRe Holdings Ltd. investment picks
Simulations Plus, Inc. (NASDAQ: SLP), a leading provider of consulting
services and software for pharmaceutical discovery and development,
today announced that Walt Woltosz, Chairman and Chief Executive Officer,
will present at the LD MICRO Conference on Wednesday, December 3, 2014,
at 2:30 p.m. PST in Track 1.
Lee Enterprises, Incorporated (NYSE:LEE), a major provider of local
news, information and advertising in 50 markets, today reported
preliminary (1) earnings of 6 cents per diluted common share
for its fourth fiscal quarter ended September 28, 2014, compared with a
loss of $1.71 a year ago.
PC Connection, Inc. (NASDAQ: PCCC), a national provider of a full range
of information technology (IT) solutions to business, government,
healthcare, and education markets, today announced that its Board of
Directors declared a special cash dividend of $0.40 per share payable
on December 15, 2014, to shareholders of record at the close of business
on December 1, 2014.
SemiLEDs Corporation (NASDAQ:LEDS), “SemiLEDs” or the “Company,” a
developer and manufacturer of LED chips and LED components, today
announced its financial results for the fourth quarter and full year of
fiscal year 2014, ended August 31, 2014.
Independent. Insightful. Trusted. Morningstar provides stock market analysis; equity, mutual fund, and ETF research, ratings, and picks; portfolio tools; and option, hedge fund, IRA, 401k, and 529 plan research. Our reliable data and analysis can help both experienced enthusiasts and newcomers.